Literature DB >> 21421898

Additive inhibitory effects of progesterone and sodium nitroprusside on uterine contractility during pregnancy.

Teresa A Orth1, Shao-Qing Shi, Kelli Williamson, Leili Shi, Linda Chambliss, Dean V Coonrod, James Balducci, Robert E Garfield.   

Abstract

Progesterone (P4) and nitric oxide (NO) suppress uterine contractility (CTX). This study compares the effects of P4 to sodium nitroprusside (SNP, an NO donor) and their combination on human CTX of term/preterm and labor/nonlabor tissues. Uterine tissues (n = 128) from women (n = 28) undergoing Cesarean were suspended in organ baths. Tissues (n ≥ 6/group) were treated with vehicle, P4, SNP, or combinations. A subset of tissues (n ≥ 2/group) from term/preterm ± labor and nonpregnant patients was analyzed with P4 alone. Analysis of variance (ANOVA) was used for statistical differences (P < .05). The combination of P4 with SNP significantly suppresses CTX (% inhibition of -127.1 ± 14.5) to the levels lower than with either P4 (-20.1 ± 8.6) or SNP alone (-72.0 ± 11.2). Suppression of P4 is similar in term, preterm, and nonpregnant tissues, with increased sensitivity in laboring tissues. This indicates that P4 or SNP alone may be used for preterm labor and their combination may be more successful.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21421898     DOI: 10.1177/1933719111398141

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  2 in total

1.  Bazedoxifene-induced vasodilation and inhibition of vasoconstriction is significantly greater than estradiol.

Authors:  Margaret A Zimmerman; Dillion D Hutson; Franck Mauvais-Jarvis; Sarah H Lindsey
Journal:  Menopause       Date:  2019-02       Impact factor: 2.953

2.  Vasodilators for women undergoing fertility treatment.

Authors:  Rosa B Gutarra-Vilchez; Xavier Bonfill Cosp; Demián Glujovsky; Andres Viteri-García; Fernando M Runzer-Colmenares; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2018-10-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.